Details
Stereochemistry | ACHIRAL |
Molecular Formula | C25H29ClN6O5 |
Molecular Weight | 528.988 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)OC1=CC(OCCN2CCN(CC2)C(C)=O)=CC3=C1C(NC4=C5OCOC5=NC=C4Cl)=NC=N3
InChI
InChIKey=MVWATCATLSSVBH-UHFFFAOYSA-N
InChI=1S/C25H29ClN6O5/c1-15(2)37-20-11-17(34-9-8-31-4-6-32(7-5-31)16(3)33)10-19-21(20)24(29-13-28-19)30-22-18(26)12-27-25-23(22)35-14-36-25/h10-13,15H,4-9,14H2,1-3H3,(H,27,28,29,30)
Molecular Formula | C25H29ClN6O5 |
Molecular Weight | 528.988 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
AZD0424, a dual selective Src/Abl kinase inhibitor that has shown evidence of anti-tumor activity in pre-clinical studies. AZD0424 participated in phase I clinical trials in patients with advanced solid tumors, but this study was terminated because of insufficient evidence of efficacy as monotherapy.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT01668550
AZD0424 will be administered as a flat dose orally once a day. One treatment cycle consists of 28 days of continuous drug administration with AZD0424, with the flexibility to introduce treatment breaks if required due to cumulative toxicity.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:49:46 GMT 2023
by
admin
on
Sat Dec 16 10:49:46 GMT 2023
|
Record UNII |
642PS51324
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C102976
Created by
admin on Sat Dec 16 10:49:46 GMT 2023 , Edited by admin on Sat Dec 16 10:49:46 GMT 2023
|
PRIMARY | |||
|
642PS51324
Created by
admin on Sat Dec 16 10:49:46 GMT 2023 , Edited by admin on Sat Dec 16 10:49:46 GMT 2023
|
PRIMARY | |||
|
CHEMBL3545177
Created by
admin on Sat Dec 16 10:49:46 GMT 2023 , Edited by admin on Sat Dec 16 10:49:46 GMT 2023
|
PRIMARY | |||
|
692054-06-1
Created by
admin on Sat Dec 16 10:49:46 GMT 2023 , Edited by admin on Sat Dec 16 10:49:46 GMT 2023
|
PRIMARY | |||
|
DB13088
Created by
admin on Sat Dec 16 10:49:46 GMT 2023 , Edited by admin on Sat Dec 16 10:49:46 GMT 2023
|
PRIMARY | |||
|
9893171
Created by
admin on Sat Dec 16 10:49:46 GMT 2023 , Edited by admin on Sat Dec 16 10:49:46 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
INHIBITOR
|